메뉴 건너뛰기




Volumn 16, Issue 1, 2016, Pages

Comparing the adverse clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: A systematic review and meta-analysis

Author keywords

Clinical outcomes; Major adverse cardiac events; Non insulin treated diabetes mellitus; Percutaneous coronary intervention; Stent thrombosis

Indexed keywords

ARTICLE; CORONARY ARTERY RECANALIZATION; HEART DISEASE; HEART INFARCTION; HUMAN; META ANALYSIS; MORTALITY RATE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STENT THROMBOSIS; SYSTEMATIC REVIEW; TARGET LESION REVASCULARIZATION; TARGET VESSEL REVASCULARIZATION; COMPLICATION; CORONARY ARTERY DISEASE; GLOBAL HEALTH; INCIDENCE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SURVIVAL RATE; TRENDS;

EID: 84997124500     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/s12872-016-0422-0     Document Type: Article
Times cited : (18)

References (25)
  • 1
    • 0842285794 scopus 로고    scopus 로고
    • Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial
    • Mathew V, Gersh BJ, Williams BA, et al. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation. 2004;109(4):476-80.
    • (2004) Circulation , vol.109 , Issue.4 , pp. 476-480
    • Mathew, V.1    Gersh, B.J.2    Williams, B.A.3
  • 2
    • 84908024284 scopus 로고    scopus 로고
    • Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial
    • Dangas GD, Farkouh ME, Sleeper LA, et al. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial. J Am Coll Cardiol. 2014;64(12):1189-97.
    • (2014) J Am Coll Cardiol , vol.64 , Issue.12 , pp. 1189-1197
    • Dangas, G.D.1    Farkouh, M.E.2    Sleeper, L.A.3
  • 4
    • 68549101842 scopus 로고    scopus 로고
    • The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
    • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
    • (2009) BMJ , vol.339
    • Liberati, A.1    Altman, D.G.2    Tetzlaff, J.3
  • 5
    • 84876826419 scopus 로고    scopus 로고
    • Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial
    • Kappetein AP, Head SJ, Morice MC, et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg. 2013;43(5):1006-13.
    • (2013) Eur J Cardiothorac Surg , vol.43 , Issue.5 , pp. 1006-1013
    • Kappetein, A.P.1    Head, S.J.2    Morice, M.C.3
  • 6
    • 78650002551 scopus 로고    scopus 로고
    • Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System)
    • Kereiakes DJ, Cutlip DE, Applegate RJ, et al. Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System). J Am Coll Cardiol. 2010;56(25):2084-9.
    • (2010) J Am Coll Cardiol , vol.56 , Issue.25 , pp. 2084-2089
    • Kereiakes, D.J.1    Cutlip, D.E.2    Applegate, R.J.3
  • 7
    • 38949202663 scopus 로고    scopus 로고
    • Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials
    • Kirtane AJ, Ellis SG, Dawkins KD, et al. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. J Am Coll Cardiol. 2008;51(7):708-15.
    • (2008) J Am Coll Cardiol , vol.51 , Issue.7 , pp. 708-715
    • Kirtane, A.J.1    Ellis, S.G.2    Dawkins, K.D.3
  • 8
    • 70350034013 scopus 로고    scopus 로고
    • Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease
    • Kirtane AJ, Patel R, O'Shaughnessy C, et al. Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. JACC Cardiovasc Interv. 2009;2(10):967-76.
    • (2009) JACC Cardiovasc Interv , vol.2 , Issue.10 , pp. 967-976
    • Kirtane, A.J.1    Patel, R.2    O'Shaughnessy, C.3
  • 9
    • 34848884238 scopus 로고    scopus 로고
    • Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients
    • Kumar R, Lee TT, Jeremias A, et al. Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients. Am J Cardiol. 2007;100(8):1187-91.
    • (2007) Am J Cardiol , vol.100 , Issue.8 , pp. 1187-1191
    • Kumar, R.1    Lee, T.T.2    Jeremias, A.3
  • 10
    • 80052147450 scopus 로고    scopus 로고
    • Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus
    • Stone GW, Kedhi E, Kereiakes DJ, et al. Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus. Circulation. 2011;124(8):893-900.
    • (2011) Circulation , vol.124 , Issue.8 , pp. 893-900
    • Stone, G.W.1    Kedhi, E.2    Kereiakes, D.J.3
  • 11
    • 79953253474 scopus 로고    scopus 로고
    • Comparison of 3-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry
    • Tada T, Kimura T, Morimoto T, et al. Comparison of 3-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry. Am J Cardiol. 2011;107(8):1155-62.
    • (2011) Am J Cardiol , vol.107 , Issue.8 , pp. 1155-1162
    • Tada, T.1    Kimura, T.2    Morimoto, T.3
  • 12
    • 84940524533 scopus 로고    scopus 로고
    • Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting
    • Thukkani AK, Agrawal K, Prince L, et al. Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting. J Am Coll Cardiol. 2015;66(10):1091-101.
    • (2015) J Am Coll Cardiol , vol.66 , Issue.10 , pp. 1091-1101
    • Thukkani, A.K.1    Agrawal, K.2    Prince, L.3
  • 13
    • 79960603166 scopus 로고    scopus 로고
    • Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial
    • Witzenbichler B, Mehran R, Guagliumi G, et al. Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial. JACC Cardiovasc Interv. 2011;4(7):760-8.
    • (2011) JACC Cardiovasc Interv , vol.4 , Issue.7 , pp. 760-768
    • Witzenbichler, B.1    Mehran, R.2    Guagliumi, G.3
  • 14
    • 85050580700 scopus 로고    scopus 로고
    • Heart failure in patients with diabetes undergoing primary percutaneous coronary intervention
    • Massalha S, Luria L, Kerner A, et al. Heart failure in patients with diabetes undergoing primary percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2016;5(6):455-62.
    • (2016) Eur Heart J Acute Cardiovasc Care , vol.5 , Issue.6 , pp. 455-462
    • Massalha, S.1    Luria, L.2    Kerner, A.3
  • 15
    • 77953712398 scopus 로고    scopus 로고
    • Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: results from the E-Five Registry
    • Jain AK, Lotan C, Meredith IT, et al. Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: results from the E-Five Registry. Heart. 2010;96(11):848-53.
    • (2010) Heart , vol.96 , Issue.11 , pp. 848-853
    • Jain, A.K.1    Lotan, C.2    Meredith, I.T.3
  • 16
    • 84876417156 scopus 로고    scopus 로고
    • Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program
    • Silber S, Serruys PW, Leon MB, et al. Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program. JACC Cardiovasc Interv. 2013;6(4):357-68.
    • (2013) JACC Cardiovasc Interv , vol.6 , Issue.4 , pp. 357-368
    • Silber, S.1    Serruys, P.W.2    Leon, M.B.3
  • 17
    • 84869085094 scopus 로고    scopus 로고
    • Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial)
    • Jensen LO, Thayssen P, Junker A, et al. Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial). Am J Cardiol. 2012;110(11):1585-91.
    • (2012) Am J Cardiol , vol.110 , Issue.11 , pp. 1585-1591
    • Jensen, L.O.1    Thayssen, P.2    Junker, A.3
  • 18
    • 77952430203 scopus 로고    scopus 로고
    • Long-term outcomes after percutaneous coronary intervention in patients with and without diabetes mellitus in Western Denmark
    • Jensen LO, Maeng M, Thayssen P, et al. Long-term outcomes after percutaneous coronary intervention in patients with and without diabetes mellitus in Western Denmark. Am J Cardiol. 2010;105(11):1513-9.
    • (2010) Am J Cardiol , vol.105 , Issue.11 , pp. 1513-1519
    • Jensen, L.O.1    Maeng, M.2    Thayssen, P.3
  • 19
    • 84943558947 scopus 로고    scopus 로고
    • Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis
    • Bundhun PK, Li N, Chen MH. Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis. Cardiovasc Diabetol. 2015;14:135.
    • (2015) Cardiovasc Diabetol , vol.14 , pp. 135
    • Bundhun, P.K.1    Li, N.2    Chen, M.H.3
  • 20
    • 84899485421 scopus 로고    scopus 로고
    • Acute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function
    • Trifunovic D, Stankovic S, Sobic-Saranovic D, et al. Acute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function. Cardiovasc Diabetol. 2014;13:73.
    • (2014) Cardiovasc Diabetol , vol.13 , pp. 73
    • Trifunovic, D.1    Stankovic, S.2    Sobic-Saranovic, D.3
  • 21
    • 84896728670 scopus 로고    scopus 로고
    • Insulin resistance is associated with coronary plaque vulnerability: insight from optical coherence tomography analysis
    • Iguchi T, Hasegawa T, Otsuka K, et al. Insulin resistance is associated with coronary plaque vulnerability: insight from optical coherence tomography analysis. Eur Heart J Cardiovasc Imaging. 2014;15(3):284-91.
    • (2014) Eur Heart J Cardiovasc Imaging , vol.15 , Issue.3 , pp. 284-291
    • Iguchi, T.1    Hasegawa, T.2    Otsuka, K.3
  • 22
    • 84891702562 scopus 로고    scopus 로고
    • National trends in utilization and outcomes of coronary revascularization procedures among people with and without type 2 diabetes in Spain (2001-2011)
    • Lopez-de-Andres A, Jimenez-Garcia R, Hernandez-Barrera V, et al. National trends in utilization and outcomes of coronary revascularization procedures among people with and without type 2 diabetes in Spain (2001-2011). Cardiovasc Diabetol. 2014;13:3.
    • (2014) Cardiovasc Diabetol , vol.13 , pp. 3
    • Lopez-de-Andres, A.1    Jimenez-Garcia, R.2    Hernandez-Barrera, V.3
  • 23
    • 84877032796 scopus 로고    scopus 로고
    • Impact of post-challenge hyperglycemia on clinical outcomes in Japanese patients with stable angina undergoing percutaneous coronary intervention
    • Kuramitsu S, Yokoi H, Domei T, et al. Impact of post-challenge hyperglycemia on clinical outcomes in Japanese patients with stable angina undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2013;12:74.
    • (2013) Cardiovasc Diabetol , vol.12 , pp. 74
    • Kuramitsu, S.1    Yokoi, H.2    Domei, T.3
  • 24
    • 84878316252 scopus 로고    scopus 로고
    • Trends in predicted 10-year risk of coronary heart disease and cardiovascular disease among U.S. adults from 1999 to 2010
    • Ford ES. Trends in predicted 10-year risk of coronary heart disease and cardiovascular disease among U.S. adults from 1999 to 2010. J Am Coll Cardiol. 2013;61(22):2249-52.
    • (2013) J Am Coll Cardiol , vol.61 , Issue.22 , pp. 2249-2252
    • Ford, E.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.